AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Eli Lilly Ranks 23rd in Trading Volume as it Acquires SiteOne Therapeutics for $1 Billion to Expand Pain Management Pipeline
Generated by AI AgentAinvest Volume Radar
Thursday, May 29, 2025 8:00 pm ET1min read
On May 29, 2025,
(LLY) saw a trading volume of 20.07 billion, ranking 23rd in the day's stock market activity. The company's stock price increased by 0.44%.Eli Lilly has announced a significant move to expand its pain management pipeline by acquiring
for $1 billion. This acquisition includes STC-004, a Phase 2-ready Nav1.8 inhibitor designed to treat chronic pain without the addictive risks associated with opioids. Therapeutics, led by CEO John Mulcahy, specializes in developing small molecule inhibitors of sodium channels to address pain and other neuronal hyperexcitability disorders. The company's portfolio includes novel drug candidates targeting Nav1.7, Nav1.8, and other ion channels, with applications in chronic cough and chronic ocular surface pain.With this acquisition, Eli Lilly aims to bolster its efforts in advancing non-opioid medicines for pain management. The deal underscores Lilly's commitment to enhancing its neuroscience pipeline and providing next-generation treatments for patients suffering from chronic pain. The transaction is expected to strengthen Lilly's position in the pain management market, offering a promising alternative to traditional opioid-based treatments.
Ainvest Volume Radar
Hunt down the stocks with explosive trading volume.
Latest Articles
Kraft Heinz Slides 1.02% as Stock Ranks 486th in Daily Trading Volume Amid Institutional Splits Earnings Woes and Dividend Strain Weigh on Investor Confidence
Dec.05 2025
AVAV's 3.15% Slide Amid 21% Volume Drop, 475th Rank Signal Earnings Optimism Fizzles
Dec.05 2025
Align Technology Extends Three-Day Rally with 0.24 Gain Ranks 452nd in $250M Turnover as Dental Sector Outperforms Peers
Dec.05 2025
PPG's 0.36% Rise Outpaces 448th-Ranked Volume as Analysts Boost Aerospace Growth Outlook
Dec.05 2025
Akamai's FedRAMP Certification Drives 31.33% Volume Surge to 445th Rank, but Stock Dips 3.59% on Investor Caution
Dec.05 2025
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet